R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
Back to search
Official data from USPTO
AMAZE CLINICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AMAZE CLINICAL
ST13
US500000088756473Class
3
Filing
88756473
Registration
6647063
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
09/30/2022
Trademark type
Word
Nice classes
3
Filing date
01/13/2020
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
09/30/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/25/2021
First use in commerce
01/25/2021
Drawing code
4
Owner type
03
Owner location
Cynthiana, KY
Examiner
MURRAY, GEORGE WILLIAM
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kentucky's Best Hemp, Inc.
Representatives
Brian W. Chellgren DENTONS BINGHAM GREENEBAUM LLP
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Topical cosmetic creams and salves; topical cosmetic creams and salves including derivative components of the hemp plantexclusively containing or derived from hemp with a delta-9-tetrahydrocannabinol concentration of not more than 0.3% on a dry weight
Publications
History of USPTO decisions and trademark events.
31 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/12/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/11/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/10/2022
EX1G
SOU EXTENSION 1 GRANTED
01/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/07/2022
IUAF
USE AMENDMENT FILED
12/29/2021
EXT1
SOU EXTENSION 1 FILED
12/29/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/29/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/29/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/19/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/19/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/19/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/20/2020
GNRT
NON-FINAL ACTION E-MAILED
07/20/2020
CNRT
NON-FINAL ACTION WRITTEN
07/20/2020
DOCK
ASSIGNED TO EXAMINER
07/13/2020
DOCK
ASSIGNED TO EXAMINER
04/01/2020
DOCK
ASSIGNED TO EXAMINER
03/31/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/16/2020
NWAP
NEW APPLICATION ENTERED
01/16/2020
Continuous trademark protection
Get notified about every new filing that threatens AMAZE CLINICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.